Seraxis Inc, based in Germantown, MD, is a pioneering company in the field of regenerative medicine, dedicated to finding a cure for type 1 diabetes. Their breakthrough technology, SR-01, combines lab-grown human islets with a unique implantation method that eliminates the need for immune suppression, offering a practical and long-term solution for insulin-dependent diabetes.
With a team of scientific and medical experts, Seraxis is focused on developing novel cell and encapsulation technologies to bring a practical cell therapy for diabetes to the clinic. Their mission is to provide patients with a means to normalize blood glucose levels without the use of immuno-suppression, offering hope and improved quality of life for millions of individuals in need.
Generated from the website